John Chung

14 papers receiving 1.6k citations

John Chung's Hit Papers

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 2014 · 1.2k citations
1.2k0+4+8Years since publication4008001.2k

Peers

John Chung
Comparison fields: 5 of 74
  • Endocrinology, Diabetes and Metabolism 1.1k
  • Oncology 394
  • Anatomy 15
  • Cancer Research 106
  • Pathology and Forensic Medicine 110
Replace David Viola with:
David Viola Italy
Jessica Read United Kingdom
Yu-Nien Sun United States
Nobuyasu Suganuma Japan
Ramona Dadu United States
Julien Hadoux France
Brian R. Untch United States
В. С. Медведев Russia
Carol Peña France
Valeria Bottici Italy
John Chung relative to David Viola Italy David Viola's profile →
Citations per field
00.5×1.5×
David Viola · 1×
Citations per year

Countries citing papers authored by John Chung

Since Specialization
Citations

This map shows the geographic impact of John Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Chung more than expected).

Fields of papers citing papers by John Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Chung. The network helps show where John Chung may publish in the future.

Co-authors

The 25 scholars most cited alongside John Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Chung Line = papers co-authored together John Chung links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Hit paper breakdown →
20141205
2 201178
3 201361
4 201951
5 201550
6
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.
200450
7 201342
8 201428
9 200921
10 200319
11 201814
12 20206
13 20144
14 20233

About John Chung

John Chung is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology, Molecular Biology, Oncology and Nephrology, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers), Urinary Bladder and Prostate Research (1 paper), Lung Cancer Research Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper), Acute Kidney Injury Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Oncology (394 citations), Anatomy (15 citations), Cancer Research (106 citations) and Pathology and Forensic Medicine (110 citations). John Chung has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Young Kee Shong, Marcia S. Brose, Johannes W. A. Smit, Martin Schlumberger, Steven I. Sherman, Christopher M. Nutting, Christian Kappeler, Rossella Elisei, István Molnár and Christelle de la Fouchardière. Their work appears in journals such as Journal of Clinical Oncology, The Lancet, Clinical and Translational Science, Journal of Thoracic Oncology and Endocrine Related Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact